Clinical Pharmacokinetics of New-Generation Antiepileptic Drugs at the Extremes of Age
- 1 January 2006
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 45 (4) , 351-363
- https://doi.org/10.2165/00003088-200645040-00002
Abstract
In recent years, several new-generation antiepileptic drugs (AEDs) have been introduced in clinical practice. These agents, which include felbamate, gabapentin, lamotrigine, levetiracetam,...Keywords
This publication has 81 references indexed in Scilit:
- Topiramate Pharmacokinetics in Children and Adults with EpilepsyClinical Pharmacokinetics, 2005
- Clinical Pharmacokinetics of LevetiracetamClinical Pharmacokinetics, 2004
- Pharmacokinetic Considerations in the Treatment of Childhood EpilepsyPediatric Drugs, 2003
- Pharmacokinetics of zonisamide in perinatal periodBrain & Development, 2002
- Age-Related Changes in Protein Binding of DrugsClinical Pharmacokinetics, 2000
- Is There a Role for Therapeutic Drug Monitoring of New Anticonvulsants?Clinical Pharmacokinetics, 2000
- Pharmacokinetic and Pharmacodynamic Changes in the ElderlyClinical Pharmacokinetics, 1998
- Clinical Pharmacokinetics of Antiepileptic Drugs in Paediatric PatientsClinical Pharmacokinetics, 1995
- Efficacy of felbamate in therapy for partial epilepsy in childrenThe Journal of Pediatrics, 1994
- Clinical Pharmacokinetics in Newborns and Infants Age-related Differences and Therapeutic ImplicationsClinical Pharmacokinetics, 1980